BSGM (BioSig Technologies, Inc.) חוב כולל להון

Biosig Technologies (BSGM) is developing heart impulse analysis systems, utilizing external contractors for hardware production, which amplifies the importance of vendor quality control. The monetization model relies on the sale of consumables and software licensing. The current debt-to-equity ratio stands at 0.00, while the price action shown below on GURU.Markets reflects profit stagnation due to low device sales volumes.

High-margin sales of disposable sensors and the software leverage of Biosig Technologies (BSGM) enable the business to scale without excessive capital expenditures on production. By analyzing changes in the debt-to-equity ratio, an investor assesses the proportion of borrowed funds within the financing structure relative to net assets, which determines the degree of financial independence and the company's ability to service obligations through operating cash flow.